Three Bridge Wealth Advisors LLC Takes Position in Intuitive Surgical, Inc. $ISRG

Key Points

• Three Bridge Wealth Advisors LLC acquired 892 shares of Intuitive Surgical, Inc. (NASDAQ:ISRG), valued at approximately $485,000, during the second quarter.
• Insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical for over $13.8 million, significantly reducing his ownership by nearly 60%.
• Analysts have issued mixed ratings for Intuitive Surgical, with a consensus of 14 "Buy," 7 "Hold," and 1 "Sell" rating, alongside a rising target price from several firms.

Three Bridge Wealth Advisors LLC acquired a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 892 shares of the medical equipment provider's stock, valued at approximately $485,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Chilton Capital Management LLC boosted its holdings in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after buying an additional 43 shares during the last quarter. Elite Financial Inc. purchased a new position in shares of Intuitive Surgical in the first quarter worth approximately $26,000. LFA Lugano Financial Advisors SA purchased a new position in shares of Intuitive Surgical in the first quarter worth approximately $30,000. TD Capital Management LLC raised its stake in Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock worth $30,000 after acquiring an additional 45 shares during the period. Finally, 1248 Management LLC bought a new stake in Intuitive Surgical during the 1st quarter worth approximately $30,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Activity

In other news, insider Gary S. Guthart sold 29,360 shares of the business's stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares of the company's stock, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Amy L. Ladd sold 335 shares of the business's stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total transaction of $147,631.15. Following the sale, the director directly owned 739 shares of the company's stock, valued at $325,669.91. This represents a 31.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 45,224 shares of company stock valued at $21,716,492. 0.70% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the stock. Erste Group Bank restated a "hold" rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Truist Financial raised their target price on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a research note on Wednesday, July 23rd. UBS Group raised their target price on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a research note on Wednesday, July 23rd. Wall Street Zen upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday. Finally, Deutsche Bank Aktiengesellschaft restated a "sell" rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Fourteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $594.19.

Intuitive Surgical Trading Up 2.1%

Shares of ISRG opened at $452.35 on Friday. The firm has a market capitalization of $162.16 billion, a P/E ratio of 63.09, a P/E/G ratio of 4.74 and a beta of 1.61. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The firm has a fifty day moving average price of $463.55 and a 200-day moving average price of $500.06.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business's revenue was up 21.4% on a year-over-year basis. During the same period in the previous year, the firm earned $1.78 earnings per share. Analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.